Indications

REDUCTIL is indicated for the management of obesity, including weight loss and maintenance of weight loss. Reductil is used as additional therapy within a weight management programme (diet, physical activity).

1. Patients with obesity due to energy imbalance whose body mass index (BMI) is 30 kg/ m² or higher.
2. Overweight patients with a BMI of 27 kg/ m² or higher due to energy imbalance, if other obesity- related risk factors such as type II diabetes or dyslipidemia are present.

BMI is calculated by taking the patient's weight, in kg, and dividing by the patient's height, in meters, squared.

Reductil may only be prescribed to patients who have not adequately responded to an appropriate weight-reducing regimen alone (hypocaloric diet and/or exercise) i.e. patients who have difficulty achieving or maintaining >5% weight loss within 3 months.

REDUCTIL is not intended for use in obese children under 18 years and elderly patients over 65 years as safety and efficacy in this population has not been established.